Recruiting

Romosozumab Use to Build Skeletal Integrity

Sponsor:

Susan L. Greenspan

Code:

NCT05058976

Conditions

Osteoporosis

Osteoporosis, Postmenopausal

Osteoporosis Fracture

Eligibility Criteria

Sex: Female

Age: 65+

Healthy Volunteers: Not accepted

Interventions

Romosozumab

Placebo

Zoledronic acid

Calcium and Vitamin D

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Susan L. Greenspan on 2024-09-19.